PlainRecalls
FDA Drug Low Class III Terminated

Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90

Reported: September 8, 2021 Initiated: August 20, 2021 #D-0784-2021

Product Description

Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90

Reason for Recall

Subpotent

Details

Units Affected
14,544 bottles
Distribution
Product was distributed nationwide.
Location
Salisbury, MD

Frequently Asked Questions

What product was recalled?
Donepezil HCL Tablets, USP, 5 mg, 90-count bottle, Rx only, Manufactured by: Jubilant Generics Ltd. India, Marketed by: Jubilant Cadista Pharmaceuticals Inc. Salisbury, MD 21801 NDC 59746-329-90. Recalled by Jubilant Cadista Pharmaceuticals, Inc.. Units affected: 14,544 bottles.
Why was this product recalled?
Subpotent
Which agency issued this recall?
This recall was issued by the FDA Drug on September 8, 2021. Severity: Low. Recall number: D-0784-2021.